BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37213446)

  • 1. A comparative study of 20% azelaic acid cream versus 5% tranexamic acid solution for the treatment of postinflammatory hyperpigmentation in patients with acne vulgaris: A single-blinded randomized clinical trial.
    Sobhan M; Talebi-Ghane E; Poostiyan E
    J Res Med Sci; 2023; 28():18. PubMed ID: 37213446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Comparison of Topical 2.5% Benzoyl Peroxide plus 5% Niacinamide to 2.5% Benzoyl Peroxide Alone in the Treatment of Mild to Moderate Facial Acne Vulgaris.
    Kaewsanit T; Chakkavittumrong P; Waranuch N
    J Clin Aesthet Dermatol; 2021 Jun; 14(6):35-41. PubMed ID: 34804354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 15% Azelaic Acid Gel in the Management of Post-Inflammatory Erythema and Post-Inflammatory Hyperpigmentation in Acne Vulgaris.
    Shucheng H; Zhou X; Du D; Li J; Yu C; Jiang X
    Dermatol Ther (Heidelb); 2024 May; 14(5):1293-1314. PubMed ID: 38734843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of Jessner's solution peel in comparison with salicylic acid 30% peel in the management of patients with acne vulgaris and postacne hyperpigmentation with skin of color: a randomized, double-blinded, split-face, controlled trial.
    How KN; Lim PY; Wan Ahmad Kammal WSL; Shamsudin N
    Int J Dermatol; 2020 Jul; 59(7):804-812. PubMed ID: 32447767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Azelaic Acid Nanocrystal-Loaded In Situ Hydrogel in the Treatment of Acne Vulgaris.
    Tomić I; Miočić S; Pepić I; Šimić D; Filipović-Grčić J
    Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33923739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability assessment and validation of the postacne hyperpigmentation index (PAHPI), a new instrument to measure postinflammatory hyperpigmentation from acne vulgaris.
    Savory SA; Agim NG; Mao R; Peter S; Wang C; Maldonado G; Bearden Dietert J; Lieu TJ; Wang C; Pretzlaff K; Das S; Vandergriff T; Lopez IE; Litzner BR; Hynan LS; Arellano-Mendoza MI; Bergstresser PR; Pandya AG
    J Am Acad Dermatol; 2014 Jan; 70(1):108-14. PubMed ID: 24176524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the Effectiveness of Stabilized Cysteamine 5% Cream Compared to Hydroquinone 4%/Ascorbic Acid 3% Combination Cream in Treating Acne-induced Post-inflammatory Hyperpigmentation: A Randomized, Controlled Study.
    Ahmadi K; Miri A; Bizaval Z; Sepaskhah M; Ranjbar S; Bagheri Z; Kasraee B
    J Clin Aesthet Dermatol; 2024 Apr; 17(4):37-41. PubMed ID: 38638185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trichloroacetic acid model to accurately capture the efficacy of treatments for postinflammatory hyperpigmentation.
    Lyons AB; Kohli I; Nahhas AF; Braunberger TL; Mohammad TF; Nicholson CL; Nartker NT; Modi K; Matsui MS; Lim HW; Hamzavi IH
    Arch Dermatol Res; 2020 Dec; 312(10):725-730. PubMed ID: 32253506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Prospective Randomized Controlled Study of Oral Tranexamic Acid for the Prevention of Postinflammatory Hyperpigmentation After Q-Switched 532-nm Nd:YAG Laser for Solar Lentigines.
    Rutnin S; Pruettivorawongse D; Thadanipon K; Vachiramon V
    Lasers Surg Med; 2019 Dec; 51(10):850-858. PubMed ID: 31302943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusidic acid cream comparatively minimizes signs of inflammation and postinflammatory hyperpigmentation after ablative fractional CO
    Wei M; Li L; Zhang XF; Li M; Wang B; Yan Y
    J Cosmet Dermatol; 2021 Jun; 20(6):1692-1699. PubMed ID: 32979860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicentre, randomized, single-blind, parallel-group study comparing the efficacy and tolerability of benzoyl peroxide 3%/clindamycin 1% with azelaic acid 20% in the topical treatment of mild-to-moderate acne vulgaris.
    Schaller M; Sebastian M; Ress C; Seidel D; Hennig M
    J Eur Acad Dermatol Venereol; 2016 Jun; 30(6):966-73. PubMed ID: 26915831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of moisturizer containing 5% panthenol, madecassoside, and copper-zinc-manganese versus 0.02% triamcinolone acetonide cream in decreasing adverse reaction and downtime after ablative fractional carbon dioxide laser resurfacing: A split-face, double-blinded, randomized, controlled trial.
    Lueangarun S; Srituravanit A; Tempark T
    J Cosmet Dermatol; 2019 Dec; 18(6):1751-1757. PubMed ID: 30945430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study.
    Kircik LH
    J Drugs Dermatol; 2011 Jun; 10(6):586-90. PubMed ID: 21637899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study.
    Grimes P; Callender V
    Cutis; 2006 Jan; 77(1):45-50. PubMed ID: 16475496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical Silymarin Cream as a Novel Therapy Versus Salicylic Acid Peels in Acne Vulgaris: A Split-Face Clinical Trial.
    Atallah DA; Badran AY; Makhlouf AG; Mekkawy MM
    J Cutan Med Surg; 2024; 28(1):22-28. PubMed ID: 37942562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The usefulness of a dermocosmetic containing Myrtus communis extract and azelaic acid for maintenance phase of adult female acne: Results from a randomized exploratory investigator-blinded comparative study.
    Bagatin E; Thouvenin MD; Bacquey A; Baradat S; Lauze C; Mengeaud V; Soares JLM; Andrade LSM; Miot HA; Rocha MA
    J Eur Acad Dermatol Venereol; 2023 Mar; 37 Suppl 2():26-30. PubMed ID: 36729399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of topical azelaic acid (20 percent cream): an overview of results from European clinical trials and experimental reports.
    Graupe K; Cunliffe WJ; Gollnick HP; Zaumseil RP
    Cutis; 1996 Jan; 57(1 Suppl):20-35. PubMed ID: 8654128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laser-Assisted Drug Delivery of Tranexamic Acid by Picosecond Laser in Postinflammatory Hyperpigmentation: A Split-Area Double Blind Randomized Prospective Study.
    Lin CH; Tsai YJ; Lin KC; Hsieh MH; Lin HP; Hsu SY; Tsai HH; Hsieh CH
    Photobiomodul Photomed Laser Surg; 2021 Nov; 39(11):711-715. PubMed ID: 34762534
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness of an epidermal growth factor-containing cream on postinflammatory hyperpigmentation after 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser treatment of acquired bilateral nevus of Ota-like macules (Hori's nevus) in Asians: A split-face, double-blinded, randomized controlled study.
    Wattanakrai P; Sindhusen S; Ploydaeng M
    J Cosmet Dermatol; 2022 May; 21(5):2031-2037. PubMed ID: 35066982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical studies of 20% azelaic acid cream in the treatment of acne vulgaris. Comparison with vehicle and topical tretinoin.
    Katsambas A; Graupe K; Stratigos J
    Acta Derm Venereol Suppl (Stockh); 1989; 143():35-9. PubMed ID: 2528257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.